GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.Ş. Logo

GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.Ş.

GENIL | IS

Overview

Corporate Details

ISIN(s):
TREGENL00016 (+1 more)
LEI:
789000A4NW6W4D8Z4H25
Country:
Türkiye
Address:
MUSTAFA KEMAL MAH. 2119. SOK. NO;3 D:2-3 ÇANKAYA/ANKARA, 06520 ANKARA
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Established in 1998, GEN İlaç ve Sağlık Ürünleri is a pharmaceutical company focused on providing global solutions for rare diseases and unmet health needs. The company leverages over 25 years of experience through a versatile business model that includes strategic partnerships with global firms and in-house development. It operates its own GMP-certified production facility and R&D center to create and manufacture competitive products for international markets. GEN specializes in treatments within key therapeutic areas such as neurology, endocrinology, nephrology, oncology, and hematology.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.Ş.. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-20 08:37
Regulatory News Service
Tender Result Notified by the Organization which Authorized by Our Company
Turkish 18.9 KB
2025-08-18 17:10
Regulatory News Service
Participation Finance Principles Information Form
Turkish 53.0 KB
2025-08-13 19:52
Regulatory News Service
01.01.2025 - 30.06.2025 period activity report
Turkish 554.5 KB
2025-08-13 19:52
Regulatory News Service
01.01.2025 - 30.06.2025 period activity report
Turkish 2.1 MB
2025-08-13 19:52
Regulatory News Service
01.01.2025 - 30.06.2025 period activity report
Turkish 11.1 KB
2025-08-13 19:37
Regulatory News Service
Financial Report
Turkish 2.3 MB
2025-08-13 19:37
Regulatory News Service
Financial Report
Turkish 2.6 MB
2025-08-13 19:37
Regulatory News Service
01.01.2025 - 30.06.2025 Dönemi Sorumluluk Beyanı
Turkish 20.0 KB
2025-08-13 08:49
Regulatory News Service
Signature of New Distribution Agreement
Turkish 20.6 KB
2025-08-13 08:27
Regulatory News Service
Correction of disclosure 11/08/2025
Turkish 13.8 KB
2025-08-11 20:41
Regulatory News Service
Support of Two Innovative R&D project within the framework of Technology Orient…
Turkish 18.3 KB
2025-08-11 17:11
Regulatory News Service
Application to CMB of Türkiye for Capital Increase
Turkish 13.2 KB
2025-08-11 14:32
Regulatory News Service
Kar Payının 2. taksitinin ödenmesi
Turkish 358.5 KB
2025-08-11 14:32
Regulatory News Service
Kar Payının 2. taksitinin ödenmesi
Turkish 38.5 KB
2025-08-01 17:29
Regulatory News Service
Company General Info Form
Turkish 12.4 KB

Automate Your Workflow. Get a real-time feed of all GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.Ş. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.Ş. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden ACUC
Advicenne Logo
Develops and commercializes therapies for rare renal diseases for patients of all ages.
France ALDVI
AegirBio AB Logo
Makes saliva-based diagnostics accessible for at-home & pro health & drug monitoring.
Sweden AEGIR
Aelis Farma Logo
Developing novel CB1 receptor inhibitors for treating brain and CNS disorders.
France AELIS
AGRONOMICS LIMITED Logo Isle of Man ANIC
ALK-Abelló Logo
Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.
Denmark ALK